Dose Planning Evaluation of Intensity-Modulated Proton Therapy (IMPT) Technique Based on In-House Dynamic Thorax Phantom

被引:0
|
作者
Vernanda, V. [1 ]
Pawiro, S. A. [1 ]
机构
[1] Univ Indonesia, Fac Math & Nat Sci, Dept Phys, Depok 16424, West Java, Indonesia
关键词
NSCLC; IMPT; Treatment planning; Bragg-peak; IMRT; TPS;
D O I
10.55981/aij.2023.1196
中图分类号
TL [原子能技术]; O571 [原子核物理学];
学科分类号
0827 ; 082701 ;
摘要
One of the drawbacks of the Intensity Modulated Radiation Therapy (IMRT) technique is that the absorbed dose in healthy tissue is relatively high. Proton beam has characteristics that can compensate for these drawbacks. The Bragg peak characteristic of a proton beam allows the administration of high radiation doses to the target organ only. Non-Small Cell Lung Cancer (NSCLC) cases are located in the vicinity of many vital organs, so radiation doses that exceed a certain limit will have a significant impact on these organs. Proton is a heavy particle that exhibits interaction patterns with tissue heterogeneity that differ from that of photon. This study aims to determine the distribution of proton beam planning doses in the NSCLC cases with the Intensity Modulated Proton Therapy (IMPT) technique and compare its effectiveness with the IMRT technique. Treatment planning was done by using TPS Eclipse on the water phantom and on the in-house thorax dynamic phantom. The water phantom planning parameters used are one field at 0 degrees and three fields at 45 degrees, 135 degrees, and 225 degrees. In this study, a single, sum, and multiple field techniques on the in-house thorax dynamic phantom were used. The evaluation was performed by calculating Conformity Index (CI), Homogeneity Index (HI), and Gradient Index (GI) parameters for each treatment planning. As a result, a bit of difference in the CI the HI values are shown between IMPT and IMRT planning. The GI values of IMPT planning are in the range between 4.15-4.53, while the GI value of IMRT is 7.89. The histogram results of the planar dose distribution show that the IMPT treatment planning provides fewer off-target organ doses than the IMRT planning. Evaluation was also carried out on the IMPT treatment planning of target organs in five areas of interest and four OAR positions. The evaluation results were then compared with the IMRT measurement data. As a result, the value of the point doses at the target organ did not differ significantly. However, the absorbed dose with the IMPT technique at four OAR positions is nearly zero, which had a large difference compared to the IMRT technique.(c) 2023 Atom Indonesia. All rights reserved
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [21] Novel in-house knowledge-based automated planning system for lung cancer treated with intensity-modulated radiotherapy
    Shao, Yan
    Guo, Jindong
    Wang, Jiyong
    Huang, Ying
    Gan, Wutian
    Zhang, Xiaoying
    Wu, Ge
    Sun, Dong
    Gu, Yu
    Gu, Qingtao
    Yue, Ning Jeff
    Yang, Guanli
    Xie, Guotong
    Xu, Zhiyong
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (11) : 967 - 982
  • [22] Evaluation of bladder dose in intensity-modulated radiation therapy of the prostate
    Higgins, P. D.
    Weaver, R.
    Dusenbery, K. E.
    MEDICAL DOSIMETRY, 2006, 31 (03) : 197 - 200
  • [23] Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC)
    Liu, Chenbin
    Yu, Nathan Y.
    Shan, Jie
    Bhangoo, Ronik S.
    Daniels, Thomas B.
    Chiang, Jennifer S.
    Ding, Xiaoning
    Lara, Pedro
    Patrick, Christopher L.
    Archuleta, James P.
    DeWees, Todd
    Hu, Yanle
    Schild, Steven E.
    Bues, Martin
    Sio, Terence T.
    Liu, Wei
    MEDICAL PHYSICS, 2019, 46 (11) : 4755 - 4762
  • [24] Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer
    Yu, Nathan Y.
    DeWees, Todd A.
    Voss, Molly M.
    Breen, William G.
    Chiang, Jennifer S.
    Ding, Julia X.
    Daniels, Thomas B.
    Owen, Dawn
    Olivier, Kenneth R.
    Garces, Yolanda I.
    Park, Sean S.
    Sarkaria, Jann N.
    Yang, Ping
    Savvides, Panayiotis S.
    Ernani, Vinicius
    Liu, Wei
    Schild, Steven E.
    Merrell, Kenneth W.
    Sio, Terence T.
    CLINICAL LUNG CANCER, 2022, 23 (08) : E526 - E535
  • [25] Biological Based Robust Optimization for Intensity-Modulated Proton Therapy
    Bai, X.
    Lim, G.
    Grosshans, D.
    Mohan, R.
    Cao, W.
    MEDICAL PHYSICS, 2018, 45 (06) : E643 - E643
  • [26] Knowledge-based planning for intensity-modulated proton therapy of the brain and base-of-skull
    Kaderka, R.
    Vu, N.
    Butkus, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1734 - S1735
  • [27] Knowledge-based intensity-modulated proton planning for gastroesophageal carcinoma
    Celik, Eren
    Baues, Christian
    Claus, Karina
    Fogliata, Antonella
    Scorsetti, Marta
    Marnitz, Simone
    Cozzi, Luca
    ACTA ONCOLOGICA, 2021, 60 (03) : 285 - 292
  • [28] Analytical models for probabilistic inverse treatment planning in intensity-modulated proton therapy
    Wahl, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S205 - S205
  • [29] Analytical models for probabilistic inverse treatment planning in intensity-modulated proton therapy
    Wahl, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S187 - S187
  • [30] Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation
    Widesott, Lamberto
    Pierelli, Alessio
    Fiorino, Claudio
    Dell'Oca, Italo
    Broggi, Sara
    Catraneo, Giovanni Mauro
    Di Muzio, Nadia
    Fazio, Ferruccio
    Calandrino, Riccardo
    Schwarz, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 589 - 596